Activation of the Akt-mTOR and MAPK pathways in dedifferentiated liposarcomas.

作者: Takeaki Ishii , Kenichi Kohashi , Kunio Iura , Akira Maekawa , Hirofumi Bekki

DOI: 10.1007/S13277-015-4232-2

关键词:

摘要: The Akt/mTOR and MAPK pathways play important roles in modulating cellular function response to extracellular signals, they are known be activated certain kinds of sarcomas. Few investigations have examined these dedifferentiated liposarcoma (DDLS), relation clinicopathological features. Clinicopathological immunohistochemical analyses were conducted using 99 DDLS specimens. An vitro study was also examine the antitumor effects an mTOR inhibitor a MEK on two cell lines. revealed that AJCC staging significant prognostic factor for overall survival tumor size, depth, location factors event-free survival. Phosphorylated Akt (pAkt), pmTOR, pS6RP, p4E-BP1, pMEK, pERK expressions positive 57.4, 52.4, 71.4, 57.1, 84.1, 50.8 % component 63 primary DDLSs. Positive staining pmTOR significantly more frequent than well-differentiated component. A univariate analysis expression associated with poor prognosis tumors retroperitoneum/ventral body cavity. inhibitors dose-dependently inhibited proliferation both lines decreased downstream pS6RP pERK, respectively. combined use enhanced antiproliferative activity. In conclusion, specimens, inhibition Our findings suggest could therapeutic target patients DDLS.

参考文章(38)
Nokitaka Setsu, Kenichi Kohashi, Fumiyoshi Fushimi, Makoto Endo, Hidetaka Yamamoto, Yusuke Takahashi, Yuichi Yamada, Takeaki Ishii, Koichirou Yokoyama, Yukihide Iwamoto, Yoshinao Oda, Prognostic impact of the activation status of the Akt/mTOR pathway in synovial sarcoma Cancer. ,vol. 119, pp. 3504- 3513 ,(2013) , 10.1002/CNCR.28255
Yuichi Yamada, Kenichi Kohashi, Fumiyoshi Fushimi, Yusuke Takahashi, Nokitaka Setsu, Makoto Endo, Hidetaka Yamamoto, Shoji Tokunaga, Yukihide Iwamoto, Yoshinao Oda, Activation of the Akt-mTOR pathway and receptor tyrosine kinase in patients with solitary fibrous tumors. Cancer. ,vol. 120, pp. 864- 876 ,(2014) , 10.1002/CNCR.28506
Yuko Ohjimi, Asami Ariyoshi, Masahiro Kikuchi, Jun Nishio, Masatoshi Naito, Masako Ishiguro, Yasuhiko Kaneko, Chikako Fujita, Hiroshi Iwasaki, Hiroki Ikegami, Establishment of a novel human dedifferentiated liposarcoma cell line, FU-DDLS-1: Conventional and molecular cytogenetic characterization International Journal of Oncology. ,vol. 22, pp. 535- 542 ,(2003) , 10.3892/IJO.22.3.535
David C. Linehan, Jonathan J. Lewis, Denis Leung, Murray F. Brennan, Influence of Biologic Factors and Anatomic Site in Completely Resected Liposarcoma Journal of Clinical Oncology. ,vol. 18, pp. 1637- 1643 ,(2000) , 10.1200/JCO.2000.18.8.1637
Deborah A Altomare, Joseph R Testa, Perturbations of the AKT signaling pathway in human cancer Oncogene. ,vol. 24, pp. 7455- 7464 ,(2005) , 10.1038/SJ.ONC.1209085
Andrew C. Hsieh, Yi Liu, Merritt P. Edlind, Nicholas T. Ingolia, Matthew R. Janes, Annie Sher, Evan Y. Shi, Craig R. Stumpf, Carly Christensen, Michael J. Bonham, Shunyou Wang, Pingda Ren, Michael Martin, Katti Jessen, Morris E. Feldman, Jonathan S. Weissman, Kevan M. Shokat, Christian Rommel, Davide Ruggero, The translational landscape of mTOR signalling steers cancer initiation and metastasis Nature. ,vol. 485, pp. 55- 61 ,(2012) , 10.1038/NATURE10912
A. Gutierrez, E. L. Snyder, A. Marino-Enriquez, Y.-X. Zhang, S. Sioletic, E. Kozakewich, R. Grebliunaite, W.-b. Ou, E. Sicinska, C. P. Raut, G. D. Demetri, A. R. Perez-Atayde, A. J. Wagner, J. A. Fletcher, C. D. M. Fletcher, A. T. Look, Aberrant AKT activation drives well-differentiated liposarcoma. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 108, pp. 16386- 16391 ,(2011) , 10.1073/PNAS.1106127108
M. Trojani, G. Contesso, J. M. Coindre, J. Rouesse, N. B. Bui, A. De Mascarel, J. F. Goussot, M. David, F. Bonichon, C. Lagarde, Soft‐tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system International Journal of Cancer. ,vol. 33, pp. 37- 42 ,(1984) , 10.1002/IJC.2910330108
Siming Li, Yan Kong, Lu Si, Zhihong Chi, Chuanliang Cui, Xinan Sheng, Jun Guo, Phosphorylation of mTOR and S6RP predicts the efficacy of everolimus in patients with metastatic renal cell carcinoma BMC Cancer. ,vol. 14, pp. 376- 376 ,(2014) , 10.1186/1471-2407-14-376
Alessandro Gronchi, Paola Collini, Rosalba Miceli, Barbara Valeri, Salvatore L. Renne, Gianpaolo Dagrada, Marco Fiore, Roberta Sanfilippo, Marta Barisella, Chiara Colombo, Carlo Morosi, Silvia Stacchiotti, Paolo G. Casali, Angelo P. Dei Tos, Silvana Pilotti, Myogenic differentiation and histologic grading are major prognostic determinants in retroperitoneal liposarcoma. The American Journal of Surgical Pathology. ,vol. 39, pp. 383- 393 ,(2015) , 10.1097/PAS.0000000000000366